XOMA Limited (NASDAQ:XOMA)
A biopharmaceutical company that discovers, develops and manufactures antibodies and other genetically-engineered protein products to treat immunological and inflammatory disorders, cancer and infectious diseases.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
RSue
(30.85)
Submitted: 4/28/2012 3:18:31 AM :
Start Price:
$2.48
XOMA Score:
-1.01
Quality scientific organization with deep pipeline in area of breakthrough novel antibody therapeutics under direction and leadership of deeply experienced Senior Vice-President of Research and Development/Chief Medical Officer Dr. Paul Rubin.
Recs
measured
(20.90)
Submitted: 4/24/2012 4:50:40 PM :
Start Price:
$2.85
XOMA Score:
-11.77
Need to have patience.A multibagger
Recs
TSIF
(99.95)
Submitted: 3/23/2012 11:03:14 AM :
Start Price:
$2.30
XOMA Score:
-9.76
Spiked 60% in early March (2012) despite $40 Million in Dilutive financing. Spike was caused because the new investors are noted hedge firms with good track records. New top/down management and refocus of drug trials may help this company, but a decade of attempts have not generated any meaningful results.
I don't know if the hedgies are right, or if changing the name of the drug will produce a different outcome, but I do know the Phase III trial results won't be out until the end of 2013, and while hte hedgies might be patient, most retail investors are not.
I expect some retrace as those who entered from the spike as wannabe's fade away.
Recs
zzlangerhans
(99.67)
Submitted: 3/7/2012 11:11:08 PM :
Start Price:
$1.89
XOMA Score:
-27.83
Investing in a Xoma, you know
You know, it's dubious
Investing in a Xoma, you know
You know, it's really dubious
There were times when I could have invested there
But you know, it was a good thing I didn't buy a share
No! Behcet's won't give cash flow!
Do you really think they'll pull through?
I don't really think they'll pull through
Investing in a Xoma, you know
You know, it's dubious
X,O,M,A,0,5,2 baby goodbye
There were times when I could have invested there
But you know, it was a good thing I didn't buy a share
Recs
jimscottage11
(< 20)
Submitted: 12/19/2011 7:00:59 AM :
Start Price:
$1.18
XOMA Score:
+93.47
New 52wk low on fri 16th 2011. could bounce
Recs
Recs
p1a5244
(64.20)
Submitted: 9/18/2011 11:20:44 PM :
Start Price:
$2.13
XOMA Score:
+1.22
9/18/11 Options Predictor Rank #33. P/C Ratio 0.075 and Call Sizzle 3.383.
Recs
rwpaules
(92.05)
Submitted: 6/20/2011 12:15:41 PM :
Start Price:
$2.30
XOMA Score:
-0.07
Poster child for R&D futility. Betting on them could be lucrative. Betting against them could be reasonable.
Recs
SCmaverick96
(< 20)
Submitted: 4/7/2011 8:33:29 PM :
Start Price:
$3.47
XOMA Score:
-30.06
I bought this stock around $5/share. Yes, I did take a huge blow from the bad research data about diabetes but I still believe I got a deal because cardiovascular is where it's at. I'm a nurse and that is what leads our nation in death tolls. The research is there, they just need to make it work. I know that's a big "IF" but I'm willing to hold on. I will buy more shares as soon as I can. I'm trying to keep my faith in the XOMA team to give that huge blockbuster drug so I can retire at 30.
Recs
hrairk
(< 20)
Submitted: 3/22/2011 10:25:16 PM :
Start Price:
$3.32
XOMA Score:
+30.77
Their "flagship" product just sank.
Recs
mukherjeepicks
(< 20)
Submitted: 2/21/2011 2:55:31 PM :
Start Price:
$5.02
XOMA Score:
-51.82
Feb 19 Weekly Picks
Recs
dangank
(< 20)
Submitted: 2/16/2011 10:30:29 AM :
Start Price:
$4.94
XOMA Score:
-50.42
The science seems to be sound, but one has the sense that no one, not even management really knows.
Recs
Recs
graniteguys
(30.66)
Submitted: 1/5/2011 2:27:05 PM :
Start Price:
$6.75
XOMA Score:
-68.37
Bought before reverse split
Hope make money back and little gain
Recs
dahabnick
(< 20)
Submitted: 12/28/2010 4:30:50 PM :
Start Price:
$4.82
XOMA Score:
-55.48
This is one of those single disease, solution focused companies. I believe diabetes is there game. Either they succeed or they don't. It will take time before there product can climb through the FDA approval jungle. Thats why Isay , at least 2 years. Anticipation until then will make it rise faster than others.
Recs
ferrarimondial32
(< 20)
Submitted: 12/28/2010 4:16:34 PM :
Start Price:
$4.82
XOMA Score:
-55.48
Blockbuster drug close to approval.
Recs
modestus1
(< 20)
Submitted: 12/28/2010 11:14:58 AM :
Start Price:
$4.88
XOMA Score:
-56.38
Drug sounds promising. Technical looks good.
Recs
blindsquirrel2
(< 20)
Submitted: 12/24/2010 1:00:07 AM :
Start Price:
$4.54
XOMA Score:
-52.72
OK I'm a sucker and have owned this company for 30 years, but the rumour is that their XOMA052 is going to finally be the blockbuster that makes this company
Recs
adhamhurani
(< 20)
Submitted: 10/3/2010 9:02:16 AM :
Start Price:
$3.06
XOMA Score:
-37.72
second phase of xoma diabetes drug look very promising , its both tested on large number of patients and follows the first successfull phase , the chances of this stock to rock are very good
Recs
hateninja
(< 20)
Submitted: 8/26/2010 5:17:18 PM :
Start Price:
$2.69
XOMA Score:
+36.28
I've bought XOMA a few times in real life - before the reverse split. Something not right about this one. I just didn't have the patience then and certainly not now.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 62 : 1 2 3 4 Next »